Delivery Order SPE2DB22D9239-SPE2DB24FDK40

Award Date 6/18/24
Potential Completion Date 7/11/24
Potential Value $26K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $8,751.19, is for the delivery of OCALIVA 10 MG TABLET 30S to support the recurring medical supply needs of military health facilities. The contract is a firm fixed-price delivery order under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $26,253.57, is for the delivery of the medication OCALIVA 10 MG TABLET 30S. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the agency to issue firm fixed-price delivery...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $26,251.35 contract is for the supply of OCALIVA 10 MG TABLET 30S, with a period of performance through September 27, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business organization based in Park Ridge, Illinois. The contract is valued at $8,751.19 and has a completion date of February 15, 2024. The contract is for the delivery of OCALIVA 10 MG TABLET 30S, a pharmaceutical product, with no set-aside designation used. This award is part of DMS Pharmaceutical Group's...
This is a $17,502.38 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for OCALIVA 10 MG TABLET 30S, a branded prescription drug, to support the recurring pharmaceutical supply needs of U.S. military health facilities. The delivery order was issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC)...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The $8,751.19 contract is for the supply of OCALIVA 10 MG TABLET 30S, a branded pharmaceutical product. The delivery order is part of a larger, single-award indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds...
This is a delivery order contract awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,751.19 firm fixed-price contract is for the delivery of OCALIVA 10 MG TABLET 30S, a pharmaceutical product. The contract is not set aside and is issued under DMS Pharmaceutical Group's existing $499,999,999 indefinite delivery contract (IDC) with the DLA, which...
This is a delivery order (SPE2DB24FE6UE) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,502.38 firm fixed-price contract is for the delivery of OCALIVA 10 MG TABLET 30S, a branded pharmaceutical product, with a performance period through June 3, 2024. The contract is associated with a larger $499,999,999 indefinite delivery contract (SPE2DB) held by DMS Pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,738.15 contract is for the delivery of OCALIVA 5 MG TABLET 30S, a prescription medication. The order is part of a larger indefinite delivery contract (IDC) valued at $499,999,999, which enables DLA to issue delivery orders for a comprehensive range of pharmaceutical products to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,502.38 contract is for the delivery of OCALIVA 10 MG TABLET 30S, with a performance period ending on May 6, 2024. The award is under the DLA's SPE2DB program, a single-award indefinite delivery contract (IDC) valued at up to $499,999,999 that allows the DLA to issue delivery orders...
  • SPE2DB22D9239
    Indefinite Delivery Contract
  • SPE2DB22D9239-SPE2DB24FDK40
    Delivery Order

This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $26,251.35 and has an ultimate completion date of July 11, 2024.

The contract is for the delivery of the pharmaceutical product OCALIVA 10 MG TABLET 30S. This delivery order is placed under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation.

Through this contract vehicle, DMS Pharmaceutical Group provides a wide array of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the medical supply requirements of the Department of Defense and Department of Veterans Affairs health facilities.

Generated 9/17/24, 10:35 AM